ETRADE Capital Management LLC lifted its holdings in Amdocs Limited (NASDAQ:DOX) by 16.5% in the fourth quarter, HoldingsChannel reports. The firm owned 7,947 shares of the technology company’s stock after buying an additional 1,128 shares during the quarter. ETRADE Capital Management LLC’s holdings in Amdocs were worth $520,000 as of its most recent SEC filing.
Several other hedge funds have also made changes to their positions in DOX. Clal Insurance Enterprises Holdings Ltd acquired a new position in shares of Amdocs in the fourth quarter valued at approximately $37,825,000. Amundi Pioneer Asset Management Inc. acquired a new position in shares of Amdocs in the third quarter valued at approximately $29,105,000. Arrowstreet Capital Limited Partnership acquired a new position in shares of Amdocs in the fourth quarter valued at approximately $21,330,000. LSV Asset Management grew its holdings in shares of Amdocs by 17.1% in the fourth quarter. LSV Asset Management now owns 1,892,750 shares of the technology company’s stock valued at $123,937,000 after purchasing an additional 275,850 shares in the last quarter. Finally, Acadian Asset Management LLC grew its holdings in shares of Amdocs by 17.4% in the fourth quarter. Acadian Asset Management LLC now owns 1,780,570 shares of the technology company’s stock valued at $116,592,000 after purchasing an additional 264,046 shares in the last quarter. Hedge funds and other institutional investors own 93.46% of the company’s stock.
DOX has been the subject of several analyst reports. Zacks Investment Research cut shares of Amdocs from a “buy” rating to a “hold” rating in a report on Monday, November 13th. BidaskClub cut shares of Amdocs from a “sell” rating to a “strong sell” rating in a report on Tuesday, December 5th. Oppenheimer reiterated a “buy” rating and set a $77.00 price target on shares of Amdocs in a report on Thursday, December 14th. Stifel Nicolaus boosted their price target on shares of Amdocs from $72.00 to $75.00 and gave the stock a “buy” rating in a report on Wednesday, January 31st. Finally, ValuEngine upgraded shares of Amdocs from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $70.71.
Amdocs (NASDAQ:DOX) last issued its quarterly earnings data on Tuesday, January 30th. The technology company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.17. The business had revenue of $977.70 million during the quarter, compared to the consensus estimate of $979.13 million. Amdocs had a net margin of 11.72% and a return on equity of 15.13%. The company’s revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.90 EPS. analysts forecast that Amdocs Limited will post 3.75 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 20th. Stockholders of record on Friday, March 30th will be given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 1.45%. The ex-dividend date is Wednesday, March 28th. This is an increase from Amdocs’s previous quarterly dividend of $0.22. Amdocs’s payout ratio is currently 28.39%.
Amdocs Company Profile
Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.